| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | – | – | – | – | – |
| SG&A | $211.76M | $230.86M | $231.72M | $192.98M | $181.45M |
| Operating Income | – | – | – | – | – |
| Interest Expense | $0.00 | $0.00 | $0.00 | $41.00K | $318.00K |
| Tax Expense | $131.59M | $216.68M | $210.68M | $297.13M | $217.39M |
| Net Income | $453.01M | $786.19M | $738.75M | $992.19M | $737.44M |
| EPS (basic) | 6.4000 | 10.8500 | 20.1700 | 27.0400 | 19.6100 |
| EPS (diluted) | 6.3500 | 10.7200 | 19.9300 | 26.7400 | 19.2900 |
| Shares (diluted) | $71.35M | $73.33M | $37.07M | $37.10M | $38.23M |